Population-based phase II trial of stereotactic ablative radiotherapy (SABR) for up to 5 oligometastases: SABR-5

BACKGROUND: Oligometastases refer to a state of disease where cancer has spread beyond the primary site, but is not yet widely metastatic, often defined as 1–3 or 1–5 metastases in number. Stereotactic ablative radiotherapy (SABR) is an emerging radiotherapy technique to treat oligometastases that r...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Cancer
Autors principals: Olson, Robert, Liu, Mitchell, Bergman, Alanah, Lam, Sonya, Hsu, Fred, Mou, Benjamin, Berrang, Tanya, Mestrovic, Ante, Chng, Nick, Hyde, Derek, Matthews, Quinn, Lund, Chad, Glick, Daniel, Pai, Howard, Basran, Parminder, Carolan, Hannah, Valev, Boris, Lefresene, Shilo, Tyldesley, Scott, Schellenberg, Devin
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2018
Matèries:
Study Protocol
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6172706/
https://ncbi.nlm.nih.gov/pubmed/30286739
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-4859-7
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars